Ditemukan 35061 dokumen yang sesuai dengan query :: Simpan CSV
Stroke is the leading cause of death and illness in Indonesia, according to Riskesdas data the prevalence continues to increase by 10.9 per mile in 2018. Non-hemorrhagic strokes are the most frequent inpatients cases at dr.Chasbullah Abdulmadjid Hospital. The hospital has made the clinical pathway, but no updates have been made after more than 3 years. This study aims to get an overview of the inputs, processes, outputs, and outcomes and challenges faced when implementing clinical pathways. This is retrospective research, uses quantitative and qualitative approaches in a system evaluation framework. The results showed that the input variables in terms of HR, funds, policies, infrastructure, drugs and medical equipment are available and ready to apply CP, the challenge is lies in the team coordination. Process variables are already running with challenges in team identification, team leader election and the CP socialization still not optimal. Output variables obtained an average LHR in accordance with CP, variants were obtained on the visit, supporting examinations, nursing services, drug consultations and medical devices. The outcome variable, there is a price difference between real and appropriate CP of Rp. 224,103 (5%), Positive difference in physiotherapy services Rp. 178,470 (143%), Visite Rp. 88,215 (26%), Nutrition Rp. 78,014 (18%), Accommodation Rp. 53,625 (10%), nursing services Rp. 45,805 (7%) and Consultation Rp. 6,750 (6%). A negative difference occurs in the drug service Rp. 123,911 (25%), Laboratory Rp. 92,465 (21%), Radiology Rp. 8,238 (1%) and Medical Devices Rp. 2,162 (1%).
Appendectomy is a surgical procedure for appendicitis, which is the most frequent surgical emergency case, as many as 250,000 in the United States and 621,435 cases in Indonesia each year. According to data from XYZ Hospital in 2018, Appendectomy is one of the top five operations with a total of 107 cases and ranks first in high-cost procedures with the difference between hospital rates and INA CBGS rates of 363%. Clinical pathway is a framework in providing health services as an effort to control the quality and cost of health services, where clinical pathways are able to reduce variations that occur in health services. This study aims to evaluate the application of clinical pathway appendectomy at XYZ Hospital in 2019. The method used is a mix method research with quantitative and qualitative methods. Sampling used a total sampling technique from all appendectomy patient data at XYZ Hospital in January - December 2019 according to the inclusion and exclusion criteria and obtained a total of 85 patient bill data. From the research results, it was found that there was a mismatch between the services provided and the clinical pathway. The biggest gap in drug use is 42%. The variations obtained were in the provision of drugs and medical devices, medical and nursing actions, and supporting examinations, this resulted in the average length of stay being longer compared to the clinical pathway, namely 3.76 days. Variations that are not in accordance with the clinical pathway can affect the quality of service and the amount of hospital bills.
The results showed that there was a significant relationship between triage assessment, emergency diagnosis, emergency intervention, investigations, doctor's consultation and doctor's disposition to the prolonged of EDLOS. The most influential factors are the triage tag factor, emergency intervention, type of diagnostic testing, type of doctor's consultation, and disposition. Other research is needed related to input and output factors to provide complete information on the causes of the prolongation of EDLOS in addition to the throughput factors in the ED. It is recommended to make a policy for physician compliance with clinical pathway, increasing the competency of emergency staff and evaluating EDLOS targets in the emergency room at RSUD dr Chasbullah Abdulmadjid Bekasi City.
Desentralisasi pelayanan kesehatan mendorong terjadinya perubahan System kelembagaan Rumah Sakit di suatu daerah. Adanya UU RI No.1 tahun 2004 tentang Perbendaharaan Negara akan member peluang bagi Pembahan Rumah Sakit pemerintah yang sebelumnya swadana menjadi Badan Layanan Umum. Badan Layanan umum melupakan suatu badan kuasi pemerintah yang tidak bertujuan mencari Iaba, meningkatkan kualitas pelayanan public dan memberikan Fleksibilitas manajemen rumah sakit. Pembahan system kelembagaan Rumah sakit memerlukan standadsasi dalam pengelolaan keuangan Sampai saat ini biaya pelayanan kesehatan bervariasi yang disebabkan oleh tidak adanya harga standar yang berdasarkan Unit Cost dari pelayanan tersebut. Hingga Diperlukan suatu perhitungan unit Cost menurut Diagnostic Related Groups yang tersusun dalam Clinical Pathway. Clinical Pathway merupakan suatu alat yang mampu untuk rneuinglcatkan mutu dan pengendalian biaya lcarena dapat menghindari tindakan yang tidak perlu dari suatu pelayanan di Rumah Sakit. Penelitian ini bertujuan untuk mengetahui Cost Of treatment Tonsilelctomi berdasarkan penyusunan Clinical Palhway di Rumah Sakit Umum Daerah Kota Bekasi tahun 2006. Tonsilektomi merupakan salah Satu tindakan pembedahan yang tertua, yang berupa tindakan pengangkatan jaringan tonsil palatine dari fossa tonsilaris_ Di inggris tahun 1987 - 1993 telah dilalcukan 70000 - 90000 tindakan tonsilelctomi dan adenodelctomi per tahun. Sedang dari catatan medis Rumah Salcit Umum Pusat Dipilihnya Tonsilektomi dalam penelitian ini dikarenakan Salah satu tindakan Pembedahan terbanyak di Rumah Sakit dan tidak membutuhkan pemanfaatan sumber daya yang bervariasi dan adanya penelitian yang menggambarkan biaya Bahan habis Pakai lebih diatas tarif yang ditentukan. Penelitian ini menggunakan metode studi kasus dengan rancangan penelitian survey kuantiuitifi Pelaksanaan penelitian ini dimulai pada bulan Maret 2007 sarnpai April 2007 dengan mempergunal-can data sekunder dari Rekam Medis pasien rawat inap dengan tindakan Tonsilektorni tahun 2006 dan data primer yang berasal dari Wawancara. Perhitungan biaya Unit Cost dihitung dengan metode Activity based Costing ( ABC ). Analisa data dilakukan secara uuivariat untuk melihat distribusi B-ekuensi dan proporsi masing - masing variable. Berdasarkan penelitian, pengelompokan menurut AR - DRG tidal: dapat diterapkan. Menurut pengelompolcan yang dilakukan di RSUD Kota Bekasi dihasilkan : Tonsilektomi murni, Tonsilektomi dengan penyakit penyerta, Tonsilelctomi dengan penyakit penyulit, Adenotonsilektomi rnurni dan Adenotonsilektomi dengan penyakit penyerta. Sedangkan penyusunan Episode Clinical Pathway didapatkan 6 tahapan yaitu Tahap pendaiizaran, Penegakkan diagnose, Pra Terapi, Terapi, Follow up dan Pulang. Hasil perhitungan Cost of Treatment Tonsilektomi di RSUD Kota Bekasi Tahun 2006 : ( 1 ). Tonsileldomi tanpa adenoidektami dengan penyakit penyulit 1 1.Kelas Perawatan Bougenvile VIP : Rp 760.582, 2.Bougenvile Utama : Rp 763.996,97, 3. WKI :Rp 577.2l0,14, 4. WKII : Rp 566.799,72, 5.WK HI I R.p s6o_o4o,'/2, 6. Mawar ; Rp 481.47102 dengan Lama hari mwar 2 hari. ( 2 ).Tonsilek1omi tanpa adenoidektomi dengan penyakit penyerta, Berdasarkan penyakit penyerta : 2.1 Anemia dan Observasi Febris ; 1. Kelas Perawatan Bougenvile VIP 1 Rp 2.096.988,08, 2.Bougcnvile Utama : Rp 2.l08.596,32, 3. WK I 2 Rp l.465.688,99, 4.WK [I I Rp l.463.302,56, 5. WK III 2 Rp 1.4-40.320,78, 6.Mawar : Rp l.164.5l8,35, 2.2 PKIB : 1. Kelas Perawatan Bougenvile VIP : Rp 762.384.46, 2. Bougenvile Utama : Rp 765.798,65, 3. WK I : Rp 553.821,90, 4, WK II : Rp 57O.16l,48, S. WK III : Rp 563.402, 6. Mawar : Rp 483.344,56, 2.3 Bronchopneumonia : 1. Kelas Perawatan Bougenvile VIP 1 Rp 767.828,46, 2 Bougenvile Utama : Rp 771.242,82, 3 WK I : Rp S59.266,07, 4. WK II: Rp 575.605,65, 5. WK III: Rp 568.846,31, 6. Mawar: Rp 488,768.71 2.4, Hipertensi siruasional ; 1. Kelas Perawatan Bougenvile VIP : Rp 765_564,12, 2. Bougenvile Un-una ; Rp 76s.97s,31, 3. WK 1 1 np 593_417,3, 4- WI( ll 1 Rp 6o9_756,ss, 5. WK III : Rp 602.997, 6. Mawar : Rp 524.433,94 (3) Tonsilekromi tanpa adenoidektomi mumi : 1.Ke1as Perawatan Bougenvile VIP : Rp 748.014, 08, 2. Bougenvile Utama : Rp 751.428,2, 3. WK I: Rp 564_641,43, 4. WK II: Rp 554.231, 5. WK IH: Rp 529.924,89, 6. Mawar : Rp 468.908,31 Median Lama hari rawat 2 hari. (4). Tonsilektomi dengan Adenodelctomi dengan penyakit penyerta : 1. Kelas Perawatan Bougenvile VIP : Rp 775,243,691 2. Bougenvile Utama : Rp 778.657,88, 3.WK I : Rp 59l.87l,05, 4. WK II : Rp 58l.460,63, 5. WK 111 : Rp 574_701,28, 6 Mawar : Rp 496.137,93Median Lama hari rawat 2 hart( 5 ) Torzsileldomi dengan Adenodektomi murni : l. Kelas Perawatan Bougenvile VIP : Rp 771.901,31, 2. Bougenvile Utama 2 Rp 775.315,50, 3. WK I 1 Rp 588,528,67, 4. WK II 1 Rp 578.l18,25, 5. WK III :Rp 571,358,90, 6. Mawar : Rp 492,795,S5. Median Lama hari rawat 2 hari. Berdasarkan hasil diatas maka diperlukan perhitungan biaya rawat inap berdasarkan penyusunan Clinical Pathway sebagai dasar penentuan tarif rumah sakit.
Decentralize in health treatment lead to some changes in Hospital institution within a certain region. Based on UU RI No. 1 year 2004 in relation of State Treasury will give opportunity to State Hospitals to change which was in self funding form to become Public Health Service. Public Health Service is a non- profit Government institution, improving public service quality and giving flexibility to Hospital management. There should be a standardization in every changes of Hospital Institution, especially in finance Sevior. Up to these days, health service fee are varies which is caused by no standardization which based on Unit Cost from its services. Therefore, Unit Cost calculation are needed according to Diagnostic Related Groups which are compiled in Clinical Pathway. Clinical Pathway is an instrument that will help to increase quality and cost control, as it can avoid tiom unnecessary actions of Hospital services. The aim of this research is to lind out Cost of treatment Tonsillectomy based on compiling Clinical Pathway in Bekasi City General Hospital in the year 2006. Tonsillectomy is one of the oldest surgery, which is a surgery of removing tonsil palatine tissue from Fossa tonsillitis. In England, within the year of 1987~ 1993 there had been 70000-90000 Tonsillectomy and Adenodektorny per year. Meanwhile, fiom the medical notes of RSUP Dr Sarjito, tonsillectomy are more then half of surgery actions in THT section. This research will use case study method with quantitative survey methodology. The implementation of this research started in March 2007 to April 2007, and using secondary data recorded hospitalized Patient with Tonsillectomy surgery action in the year 2006 and also using primary data which was based on direct interviews. Unit cost are calculated using Activity Based Costing (ABC) method. Data analysis is implemented as univariatly to see frequency distribution and proportion on each variable. Based on research grouping according AR-DRG can not be implemented. Based on grouping that had been implemented at Bekasi City General Hospital are as followed: Pure Tonsillectomy, Tonsillectomy with following disease, Tonsillectomy with complication disease, Pure Adeno Tonsillectomy and Adeno Tonsillectomy with following disease. In the meantime, compiling of Clinical Pathway episode is obtaining 6 steps which are: registration , established diagnose, pre-therapy, therapy, follow up then Horne. Final Clinical Pathway is needed to get clinical pathway concept as a tool to increase quality and cost control. The result cost of treatment tonsillectomy at Bekasi City General hospital in 2006 ( 1 ). Tonsillectomy with complication disease 1 1. Bougenvile VIP : Rp 760.582, 2.Bougenvile Utama : Rp 763.996,97, 3. WK I : Rp 577.2l0,l4, 4. WK II: Rp s66.799,72, 5_wK In ; Rp 560.040,72, 6. Mawar ; Rp 481.47102 with time length of stay 2 days. ( 2 ). T onsilectongr with following disease, Based on following disease : 2.1 Anenuh dan Observasi Fabris ; I. Bougenvile VIP : Rp 2.096.988,08, 2.Bougenvile Utama : Rp 2. 108.596,32, 3. WK I : Rp l_465.688,99, 4.WK II 1 Rp 1.463.3o2,s6, 5. WK III . Rp 1.440.320,78, 6.Mawar 1 Rp 1-164.51s,35, 2.2 PKYB : 1. Bougenvile VIP : Rp 762.384.46, 2. Bougenvile Utama 2 Rp '765.798,65, 3. WK I 2 Rp 553.82l,90, 4. WK 1] : Rp 570.161,48, 5. WK III : Rp 563.402, 6. Mawar : Rp 483.344,56, 2.3 Bronchopneumonia: 1. Bougenvile VIP : Rp 767.828,46, 2 Bougenvile Utama : Rp 77l.242,82, 3 WK I : Kp 559.266,07, 4. WK II: Rp 575.605,65, 5. WK III: Rp 568.846,3l, 6. Mawar: Kp 488.768.73, 2.4, Hiperteusi simasional ; 1. Bougenvile VIP : Rp 765.564,l2, 2. Bougenvile Utama 1 Rp 768.978,31, 3. WK I : Rp 593.417,3, 4. WK Il : Rp 609.756,88, 5. WK III : Rp 602.997, 6. Mawar 1 Rp 524.433,94 (3) Pure f0l|Si??L?f0I|Q?Z l. Bougenvile VIP : Rp 748.014, 08, 2. Bougenvile Utama ; Rp 751.42s,2, 3. WK 1; Rp 564.641,43, 4. WK II: Rp 554.231, 5. WK 111: Rp 529.924,89, 6. Mawar 1 Rp 468.908,3l with time length of stay 2 days. ( 4 ). Adenotonsilectongmy with following disease: l. Bougenvile VIP :Rp 775_243,69S, 2. Bougenvile Utama 1 Rp 778.657,88, 3.WK I 1 Rp 591.871,05, 4. WK II 1 Rp 58] .460,63, 5. WK HI 1 Rp 5?74.7Ol,28, 6 Mawar : Rp 496.l37,93 with time length of stay 2 days( 5 ) Pure Adenotonsileldomiz I. Bougenviie VIP : Rp 771_90l,3l, 2. Bougenvile Utama : Rp 775_3I5,S0, 3. WK I : Rp 588,528,67, 4. WK II : Rp 578.l18,25, 5. WK 111: Rp57l,358,90, 6. Mawar : Rp 492,795,55_ With time length of stay 2 days. Based on results above, therefore, we need calculation of hospitalised fee based on compiling Clinical Pathway as a benchmark to decide the hospital tariff.
Untuk mengevaluasi terhadap penerapan clinical pathway bagi pasien skizofrenia di Rumah Sakit Jiwa dr. Radjiman Wediodiningrat Lawang, dilakukan penelitian menggunakan desain cross-sectional retrospektif dengan pengambilan sampel berdasarkan proporsi kejadian variabel yang diukur. Hasil yang diperoleh adalah indikator kejadian percobaan bunuh diri menurun dari 6% menjadi 2% (p= 0,097). Indikator kejadian pasien lari 6% vs 5% (p = 0,756). Kejadian pasien jatuh menurun dari 2% menjadi nol (p= 0,155). Indikator kejadian pasien yang difiksasi satu kali menurun dari 26% menjadi 12%, sedangkan pasien yang difiksasi lebih dari satu kali menurun dari 12% menjadi 10% (p = 0,028). Indikator kejadian infeksi nosokomial akibat scabies terdapat peningkatan bermakna dari tidak ada kasus menjadi 19% (p = 0,001). Tidak ada kejadian infeksi nosokomial akibat luka fiksasi. Kejadian re-hospitalisasi sebanyak satu kali mengalami penurunan sesudah penerapan clinical pathway sebanyak 7% (26% menjadi 19%). Kejadian re-hospitalisasi lebih dari satu kali meningkat sebesar 42% (10% menjadi 52%). Interval re-hospitalisasi kurang dari satu bulan menurun dari 2% menjadi 1%. Rata-rata lama rawat menurun dari 80,8 menjadi 59,16 (p = 0,04). Sedangkan indikator kepuasan pelanggan terdapat kecenderungan terjadi peningkatan setelah penerapan clinical pathway, namun pada tahun 2011 terdapat tren yang menurun. Saran: perlu dilakukan penelitian lebih lanjut tentang adanya faktor-faktor selain clinical pathway, yang berpengaruh terhadap perubahan tingkat keselamatan pasien, re-hospitalisasi, efektivitas pelayanan, serta perlunya revisi formulir clinical pathway.
This study was conducted to evaluate the implementation of clinical pathway for patients with schizophrenia in the Dr. Radjiman Wediodiningrat Mental Hospital. This research used cross-sectional design with retrospective sampling events based on the proportion of measured variables. We found that the incidence of suicide attempts decreased from 6% to 2% (p = 0.097). There was no different of run away event ( 6% vs 5%; p = 0.756). The incidence of patient fell decreased from 2% into zero (p = 0.155). The events of one-time fixation decreased from 26% to 12%, while patients who got more than once fixation declined from 12% to 10% (p = 0.028). The incidence of nosocomial infection scabies increased to 19% (p = 0.001). There was no wound infections from fixation events. The incidence of re-hospitalization, one-time decreased after the implementation of clinical pathways as much as 7% (26% to 19%). But the incidence of rehospitalization for more than one time increased by 42% (10% to 52%). The average length of stay decreased from 80.8 to 59.16 (p = 0,04). In term of customer satisfaction, there was a tendency an increase after the implementation of clinical pathways, but in 2011 there was a downward trend. The study suggest to asses factor beside clinical pathways that influence patient safety, rehospitalized, care of effectivenes and review the clinical pathway form.
This thesis discusses about the evaluation of the suitability of the clinical pathway application of clinical pathway diarrhea in infants, with the aim of obtaining the results of an evaluation of the implementation of Clinical Pathway diarrhea in infants and the calculation of unit cost in cases of diarrhea in infants in Bhakti Rahayu General Hospital Denpasar. The research design used is the mix method, namely quantitative and qualitative research designs. The study was conducted in May 2019 to June 2020. The results obtained are still getting some variations in the services provided to patients so that the total cost of action in accordance with clinical pathway is Rp. 675,281, - with the real cost of services provided at Rp. 1,045,212 , - which means there is still a difference of Rp. 369,931, -.
Background : Osteoarthritis (OA) is the most common disease of joint disorders found in adults in the world, according to WHO in its report entitled The Burden of Musculoskeletal Conditions at The Start of the New Millennium, writing that osteoarthritis is one of the main causes of morbidity. in the world and has a major impact on the burden of health costs. Goal :Analyze factors related to cost variation Total action knee arthroplasty at dr. Chasbullah Abdulmadjid (RSCAM) Bekasi City Methode : The approach used in this research is quantitative and the ANOVA test is carried out on the influence between the independent variable and the dependent variable. The samples used were 29 patients who were taken according to the inclusion criteria which included age, gender, LOS, room class, severity level and treatment costs consisting of accommodation, doctor visits, consultations, medical support, medical procedures, drugs and medical equipment. Result : The frequency distribution of respondents based on age is 11 people (37.9%), old age 15 people (51.9%) and elderly people are 3 people (10.3%), with the majority of respondents being 24 women (82.8%). The highest number of treatment classes is in class 3 as many as 16 people (55.2%) and the highest severity level is severity level I as many as 16 people (55.2%), where the highest LOS during treatment is 5-10 days as many as 25 people (66.2%). The average total cost for accommodation is Rp.1,937.29.37, for doctor visits Rp.9,848.04, consultation Rp.5.8442.31, medical support Rp.118,834.96, medical treatment Rp. 508.153.50, medicine Rp. 36,554.39 and the average cost of medical equipment services is Rp. 650.165.39. In the ANOVA test results, age and length of stay have a significant relationship with treatment costs with a P value of 0.033 for age and a P value of 0.000 for LOS
RSUD Tarakan merupakan rumah sakit umum daerah milik Pemerintah Provinsi Daerah Khusus Jakarta yang ditetapkan sebagai rumah sakit pengampu layanan stroke baik untuk kasus stroke infark maupun kasus stroke hemoragik. Dalam memberikan pelayanan kasus stroke hemoragik baik severity I, II maupun III, RSUD Tarakan mengalami selisih negatif antara rata-rata tarif INA CBG’s terhadap rata-rata tarif rumah sakit. Penelitian ini bertujuan untuk mengetahui besaran biaya satuan perawatan stroke hemoragik sebagai langkah awal untuk menganalisis biaya. Dengan diketahuinya besaran biaya satuan antara layanan aktual dan clinical pathway maka dapat diketahui faktor-faktor apa saja yang dapat menyebabkan inefisiensi di dalam perawatan stroke hemoragik. Dari faktor-faktor inefisiensi yang telah diketahui maka dapat diketahui pula nilai cost recovery rate untuk menentukan upaya efisiensi dan penerapan cost containment sebagai rekomendasi bagi manajemen RSUD Tarakan. Penelitian ini menggunakan metode deskriptif dengan pendekatan kualitatif yang mengolah data primer dari hasil wawancara mendalam dan data sekunder melalui telaah dokumen dengan menggunakan metode Activity Based Costing. Hasil penelitian ini menunjukkan bahwa biaya satuan rata-rata perawatan stroke hemoragik kelas 1 sebesar Rp. 18.296.787,-, kelas 2 sebesar Rp. 32.496.824,- dan kelas 3 sebesar Rp. 15.595.005. Nilai cost recovery rate mencapai lebih dari 100% pada perawatan stroke hemoragik baik severity I, II maupun III dengan LOS 1-7 hari. Dari hasil upaya efisiensi berdasarkan layanan dan biaya disimpulkan bahwa faktor-faktor yang menyebabkan terjadinya inefisiensi pada perawatan stroke hemoragik adalah keterpakaian tempat tidur yang rendah khususnya kelas 2, utilitas alat yang rendah, biaya pemakaian obat yang tinggi serta LOS yang memanjang. Dari faktor-faktor tersebut dilakukan pemetaan terhadap 4 tahap cost containment. Cost Awareness dilakukan dengan pemantapan sosialisasi kepada dokter dan seluruh pegawai mengenai pentingnya kesadaran biaya di rumah sakit, cost management dilakukan dengan melakukan strategi optimalisasi sumber daya manusia dan pemakaian obat-obatan, optimalisasi proses layanan perawatan stroke hemoragik dan sarana-prasarana yang diberikan seperti penggabungan kelas 2 ke dalam ruang rawat kelas 3 yang sudah sesuai standar KRIS serta otomatisasi sistem informasi rumah sakit. Cost monitoring dilakukan dengan memperkuat fungsi pengawasan pihak-pihak pengendali biaya dan cost incentive dilakukan dengan memberikan reward kepada dokter maupun pegawai rumah sakit yang berkontribusi dalam melakukan efisiensi biaya rumah sakit.
RSUD Tarakan is a regional public hospital owned by the Provincial Government of the Special Region of Jakarta which is designated as the hospital in charge of stroke services for both infarct stroke cases and hemorrhagic stroke cases. In providing services for hemorrhagic stroke cases of severity I, II and III, RSUD Tarakan experiences a negative difference between the average INA CBG's tariff and the average hospital tariff. This study aims to determine the unit cost of hemorrhagic stroke care as a first step to analyzing costs. By knowing the amount of unit costs between actual services and clinical pathway, it can be known what factors can cause inefficiencies in hemorrhagic stroke treatment. From the inefficiency factors that have been known, the value of cost recovery rate can also be known to determine efficiency efforts and the application of cost containment as a recommendation for the management of RSUD Tarakan. This study uses a descriptive method with a qualitative approach that processes primary data from in-depth interviews and secondary data through document review using the Activity Based Costing method. The results of this study indicate that the average unit cost of class 1 hemorrhagic stroke treatment is Rp. 18,296,787, class 2 is Rp. 32,496,824, and class 3 is Rp. 15,595,005. The cost recovery rate value reached more than 100% in hemorrhagic stroke treatment both severity I, II and III with LOS 1-7 days. From the results of efficiency efforts based on services and costs, it is concluded that the factors that cause inefficiency in hemorrhagic stroke treatment are low bed utilization, especially class 2, low equipment utility, high drug usage costs and prolonged LOS. From these factors, a mapping of the 4 stages of cost containment was carried out. Cost Awareness is carried out by strengthening socialization to doctors and all employees regarding the importance of cost awareness in hospitals, cost management is carried out by carrying out strategies to optimize human resources and the use of drugs, optimizing the hemorrhagic stroke treatment service process and facilities provided such as the incorporation of class 2 into class 3 treatment rooms that are in accordance with KRIS standards and automation of hospital information systems. Cost monitoring is carried out by strengthening the supervisory function of cost control parties and cost incentives are carried out by providing rewards to doctors and hospital employees who contribute to hospital cost efficiency.
